Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
TRAQinform Assessment of Immunotherapy Response
- Status
- COMPLETED
- Phase
- N/A
Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study
- Status
- COMPLETED
- Phase
- N/A
Bioequivalence Binimetinib 3 x 15 mg and 45 mg Formulations
- Status
- COMPLETED
- Phase
- PHASE1
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
T3011 in Combination With Cobimetinib in Patients With Advanced Melanoma
- Status
- SUSPENDED
- Phase
- PHASE2
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
CD8 Minibody Repeatability Study
- Status
- TERMINATED
- Phase
- PHASE2
Analysis of Circulating Exosomes in Melanoma Patients
- Status
- UNKNOWN
- Phase
- N/A
Pharmacokinetic Profiling of Pembrolizumab and Nivolumab in Patients With Melanoma and/or Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Status
- RECRUITING
- Phase
- PHASE3
KD6001 in Combination With Anti-PD-1 Antibody in Patients With Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Retrospective Assessment of Adverse Events-related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma
- Status
- COMPLETED
- Phase
- N/A